Cryoablation – Efficient and Practical Treatment Approach to Pelvic Desmoid Tumour (Pelvic Fibromatosis)


Pelvic desmoid tumours, also known as pelvic fibromatosis, pose a significant challenge in the medical field due to their invasive nature and complex treatment requirements. However, advancements in medical technology have introduced promising treatment approach called cryoablation, offering newfound hope to patients battling this condition. In this article, we delve into the efficiency and practicality of cryoablation treatment for pelvic desmoid tumours.

Understanding Pelvic Desmoid Tumours:

Pelvic desmoid tumours are rare, locally aggressive soft tissue tumours that typically arise in the abdominal wall, pelvis, or retroperitoneum. These tumours can infiltrate surrounding structures, causing pain, bowel or bladder dysfunction, and other complications. Traditional treatment methods such as surgery and radiation therapy often present challenges due to the tumour’s proximity to vital organs and the risk of recurrence.

The Emergence of Cryoablation:

Cryoablation, also known as cryotherapy or cryosurgery, has emerged as a minimally invasive alternative for treating pelvic desmoid tumours. This technique involves the controlled freezing of tumour tissue, effectively destroying cancerous cells while preserving surrounding healthy tissue. Unlike traditional surgery, cryoablation offers several advantages, including shorter recovery times, a reduced risk of complications, and minimal scarring.

Efficiency of Cryoablation in Pelvic Desmoid Tumours treatment :

Numerous studies have demonstrated the efficiency of cryoablation in treating pelvic desmoid tumours. By delivering extreme cold temperatures (-20°C to -180°C) directly to the tumour site, cryoablation induces cellular death, halting tumour growth, and alleviating symptoms. Moreover, cryoablation can be performed as an outpatient procedure, allowing patients to resume their daily activities shortly after treatment.

The Practicality of Cryoablation in treating Pelvic Desmoid Tumours:

One of the most significant advantages of cryoablation is its practicality in treating pelvic desmoid tumours. Unlike traditional surgery, which may require extensive hospital stays and post-operative care, cryoablation offers a more convenient and cost-effective treatment option. Additionally, cryoablation can be repeated if necessary, providing a versatile approach to managing recurrent or residual tumours.

Safety and Efficacy:

Safety is paramount in any medical procedure, and cryoablation has demonstrated a favourable safety profile in treating pelvic desmoid tumours. Studies have reported low rates of complications such as infection, nerve damage, and bleeding, making cryoablation a viable option for patients who may not tolerate more invasive treatments. Furthermore, cryoablation has shown comparable efficacy to traditional therapies, with high rates of tumour control and symptom relief.

Patient Experience and Quality of Life:

The patient experience plays a crucial role in evaluating the success of any treatment modality. Cryoablation offers patients a less traumatic alternative to surgery, with minimal pain and discomfort during and after the procedure. Moreover, the shorter recovery times associated with cryoablation enable patients to return to their normal routines sooner, improving their overall quality of life.

Future Directions and Considerations:

As technology continues to evolve, so will the applications of cryoablation in treating pelvic desmoid tumours. Ongoing research aims to refine techniques, optimise treatment protocols, and expand the use of cryoablation to other types of tumours and anatomical locations. Additionally, multidisciplinary collaboration between surgeons, radiologists, and oncologists is essential for ensuring the successful integration of cryoablation into clinical practice.


In conclusion, Cryoablation represents a significant advancement in the management of pelvic desmoid tumours, offering patients a safe, efficient, and practical treatment approach. With its minimal invasiveness, favourable safety profile, and promising outcomes, cryoablation has the potential to revolutionise the way we approach the treatment of pelvic desmoid tumours, providing renewed hope for patients and clinicians alike. As research and technology continue to progress, cryoablation will undoubtedly play an increasingly prominent role in the fight against this challenging disease.